SimonMed picks SwiftMR for nationwide MRI enhancement rollout
SimonMed selected AIRS Medical’s SwiftMR as its enterprise-wide MRI enhancement platform. The FDA-cleared software will be deployed across SimonMed’s national outpatient imaging network.
SimonMed has selected AIRS Medical’s SwiftMR as its enterprise-wide MRI enhancement platform. The FDA-cleared AI software will be deployed across SimonMed’s nationwide imaging center network.
The Scottsdale, AZ-based provider said the decision followed an evaluation of MRI AI platforms. SimonMed said the selection is part of a broader effort to improve MRI quality, access, and consistency across its sites.
SwiftMR is an MRI image enhancement platform developed by AIRS Medical. The software uses deep learning to improve image quality and reduce MRI scan times, according to AIRS Medical.
AIRS Medical said the deployment will span more than 170 SimonMed centers nationwide. SimonMed operates centers across 10 states and is supported by more than 300 subspecialty-trained, board-certified radiologists.
SimonMed said SwiftMR’s vendor-neutral architecture allows deployment across different scanner types, manufacturers, and clinical environments. The software does not require additional hardware investment, according to the company.
Sean Raj, MD, chief medical officer and chief innovation officer at SimonMed, said the company evaluated major MRI AI platforms before selecting AIRS Medical. He cited SwiftMR’s “reliable performance across diverse scanner environments.”
AIRS Medical said SwiftMR is FDA 510(k)-cleared to support MRI scan time reductions of up to 50% in the U.S. The company said clinical results vary by scanner model, field strength, imaging protocol, and site configuration.
The SimonMed announcement follows AIRS Medical’s expanded FDA clearance for SwiftMR to operate with original equipment manufacturer deep-learning reconstruction pipelines. AIRS Medical announced that clearance on April 15.
Under that clearance, SwiftMR can work with installed OEM deep-learning systems to provide additional scan time reduction. AIRS Medical said the software can also extend AI-powered enhancement to pulse sequences not covered by an OEM system.
SwiftMR’s full-coverage version has been in clinical use since 2023, according to AIRS Medical. The company said the platform is deployed at more than 1,700 imaging centers and hospitals across more than 40 countries.
Companies:Airs Medical, SimonMed Imaging
Sources
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
SimonMed highlights role in large global X-ray AI study
The study analyzed 258,373 X-rays from 100 medical centers across 26 countries and evaluated the Rayvolve AI Suite across trauma, chest, measurement, and bone age use cases.
Neurophet names Lawrence Tanenbaum scientific advisor
The neuroradiologist and former RadNet CTO will advise the neuroimaging AI company as it seeks to strengthen clinical validation and U.S. market expansion.
CMR-CLIP AI model interprets cardiac MRI scans with high accuracy
The model was trained on more than 13,000 cardiac MRI studies and linked moving heart images with clinical radiology reports, according to the research team.
Flywheel integrates with AWS HealthImaging
The integration combines AWS HealthImaging’s cloud-based DICOM storage with Flywheel’s imaging data orchestration tools for clinical trials, research, and AI development.
GE HealthCare opens free HelloAI training program
The company is making the HelloAI Professional track available at no cost, adding more than 20 hours of on-demand healthcare AI education.
Siemens unveils CT-guided PCI workflow system
The system combines Syngo.CT Coronary Cockpit and Syngo PCI Connect to transfer preprocessed coronary CT angiography data into the cath lab.
AZmed gets FDA clearance for expanded AZtrauma scope
The clearance expands AZtrauma beyond fracture detection to include joint effusions and dislocations on X-rays in adults and children ages 2 years and older.
HOPPR launches mammography vision-language model
The HOPPR EB 2D Mammo Narrative Model generates structured narrative output from 2D mammography images for breast imaging workflow applications.
DeepHealth secures AI clearances for neuro, prostate tools
The regulatory milestones cover Neuro Suite Brain Health and Brain Age, LumbarMR, and Prostate AI within DeepHealth’s clinical AI portfolio.
Philips introduces SmartIQ for Azurion coronary imaging
The coronary imaging technology adds an ultra-low-dose protocol for Philips’ Azurion image-guided therapy platform and is available in Europe and selected markets.
Azra AI, RevealDx partner on lung nodule AI
Azra AI will integrate RevealAI-Lung into its incidental findings and oncology workflow platform.
Rivanna receives FDA clearance for Accuro XV ultrasound
Rivanna received FDA 510(k) clearance for Accuro XV, a diagnostic ultrasound system for musculoskeletal imaging. The company is also developing AI tools for bone visualization and fracture detection.